Yang Dan, Hou Xintong, Yang Guimei, Li Mengnan, Zhang Jian, Han Minmin, Zhang Yi, Liu Yunfeng
Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
First Clinical Medical College, Shanxi Medical University, Taiyuan, People's Republic of China.
Diabetes Metab Syndr Obes. 2022 Sep 25;15:2939-2950. doi: 10.2147/DMSO.S380577. eCollection 2022.
The hypothalamus is indispensable in energy regulation and glucose homeostasis. Previous studies have shown that pro-opiomelanocortin neurons receive both central neuronal signals, such as α-melanocyte-stimulating hormone, β-endorphin, and adrenocorticotropic hormone, as well as sense peripheral signals such as leptin, insulin, adiponectin, glucagon-like peptide-1, and glucagon-like peptide-2, affecting glucose metabolism through their corresponding receptors and related signaling pathways. Abnormalities in these processes can lead to obesity, type 2 diabetes, and other metabolic diseases. However, the mechanisms by which these signal molecules fulfill their role remain unclear. Consequently, in this review, we explored the mechanisms of these hormones and signals on obesity and diabetes to suggest potential therapeutic targets for obesity-related metabolic diseases. Multi-drug combination therapy for obesity and diabetes is becoming a trend and requires further research to help patients to better control their blood glucose and improve their prognosis.
下丘脑在能量调节和葡萄糖稳态中不可或缺。先前的研究表明,促黑素细胞皮质激素原神经元既接收中枢神经信号,如α-黑素细胞刺激素、β-内啡肽和促肾上腺皮质激素,也感知外周信号,如瘦素、胰岛素、脂联素、胰高血糖素样肽-1和胰高血糖素样肽-2,通过其相应受体和相关信号通路影响葡萄糖代谢。这些过程中的异常可导致肥胖、2型糖尿病和其他代谢性疾病。然而这些信号分子发挥作用的机制仍不清楚。因此,在本综述中,我们探讨了这些激素和信号对肥胖和糖尿病的作用机制,以提出肥胖相关代谢性疾病的潜在治疗靶点。肥胖和糖尿病的多药联合治疗正成为一种趋势,需要进一步研究以帮助患者更好地控制血糖并改善预后。